Shandong University of Traditional Chinese Medicine, Jinan, China.
Eur Rev Med Pharmacol Sci. 2017 May;21(9):2034-2038.
The purpose of this work was to examine the relationship between abnormal TOX3 gene methylation and the occurrence of polycystic ovarian syndrome (PCOS).
We selected 30 patients with PCOS and 30 control volunteers. Serum luteinizing hormone, estradiol, testosterone, and thyroid stimulating hormone were detected, methylation, mRNA and protein level of TOX3 were measured.
Serum luteinizing hormone, estradiol, testosterone, and thyroid stimulating hormone were significantly higher and follicle stimulating hormone and prolactin were significantly lower in PCOS patients than in the control group. Methylation of the promoter of TOX3 in serum and granular cells was significantly lower in PCOS than in the control group. The mRNA levels of TOX3 in serum were lower in the PCOS group. The levels of TOX3 protein in serum and granular cells was significantly lower in PCOS group than in the control group.
Overall, abnormal TOX3 methylation possibly resulting in changes in TOX3 protein expression is closely related to the occurrence of PCOS and may play a role the development of the pathology.
本研究旨在探讨异常 TOX3 基因甲基化与多囊卵巢综合征(PCOS)发生的关系。
选取 30 例 PCOS 患者和 30 例健康志愿者。检测血清黄体生成素、雌二醇、睾酮、促甲状腺激素,检测 TOX3 基因的甲基化、mRNA 和蛋白水平。
与对照组相比,PCOS 患者的血清黄体生成素、雌二醇、睾酮和促甲状腺激素明显升高,卵泡刺激素和催乳素明显降低。TOX3 基因在血清和颗粒细胞中的启动子甲基化水平在 PCOS 组中明显降低。PCOS 组血清 TOX3 的 mRNA 水平降低。与对照组相比,PCOS 组血清和颗粒细胞中 TOX3 蛋白水平显著降低。
综上所述,异常的 TOX3 甲基化可能导致 TOX3 蛋白表达的改变,与 PCOS 的发生密切相关,可能在发病机制中发挥作用。